DAY TWO - Friday 6th October
Session is held in the Keltie Cove Room
Breakfast is supplied for attendees
Breakfast is supplied for attendees
7:00 – 8:30
- 30min – Ultrasound physics, universal basics and considerations – Kim Theil – BK Medical International Product Specialist
- 30min – BK Ultrasound system familiarity, functionality, and workflows. – Adrian Barker – BK Medical National Product Manager
- 30mins – Hands-on workstations.
Clinical decision making and consent in HPB surgery
Chairs Dr Michael Crawford and Dr Emily Olive
Chairs Dr Michael Crawford and Dr Emily Olive
8:30 – 8:45
Tailoring diagnosis and treatment for patients with gallstones – Dr Phil de Reuver
8:45 – 9:00
Cholecystectomy for gallbladder polyps – is it ever appropriate? Professor Jonathan Koea
9:00 – 9:15
Consent in HPB surgery – what do you tell the patient? – Professor Vijayaragavan Muralidharan
9:15 – 9:30
The value and limitations of the MDT meeting for HPB cancers – Dr Charles Pilgrim
9:30 – 9:45
HPB cancer surgery -the anaesthetists/intensivist perspective – Dr Benjamin Olesnicky
9:45 – 10:00
Discussion
10:00 – 10:30
Keynote talk “Evaluating Surgical Innovation”
Introduction – Professor Tom Hugh
Speaker – Professor David Beard
- Professor and Surgical & Complex Intervention Trials Program Lead at the NHMRC CTC, University of Sydney
- Professor of Musculoskeletal and Surgical Sciences at the Nuffield
- Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) in the University of Oxford
- Director of the Royal College of Surgeons (RCS) Surgical Intervention Trials Unit (SITU-NDORMS)
The role of innovation and technology in value-based care in HPB surgery
Chairs Dr Eunice Lee and Dr Joel Lewin
Chairs Dr Eunice Lee and Dr Joel Lewin
11:00 – 11:15
Surgical outcomes are improved by the devices and equipment we use (stapling and energy devices, 3D systems, 4K monitors) – Professor Vincent Lam
11:15 – 11:30
Laparoscopy has improved the value of HPB surgery – Dr Mehan Siriwardhane
11:30 – 11:45
Robotics has improved the value of HPB surgery – Dr David Cavallucci
11:45 – 12:00
Where does the learning curve of MIS tip to gain the benefits – Dr David Yeo
12:00 – 12:15
Who decides on whether new technology in HPB surgery should be used? – Professor Guy Maddern
12:15 – 12:30
Discussion
12:30 – 12:40
AGM
Free papers: Pancreas (Prize for best presentation)
Chairs Dr Ben Loveday and Dr Dan Kilburn
Room – Grand Ballroom One & Two
Chairs Dr Ben Loveday and Dr Dan Kilburn
Room – Grand Ballroom One & Two
13:30 – 13:39
Markov model decision analysis suggests that screening guidelines for branch duct intraductal papillary mucinous neoplasms <3cm are not cost effective in an Australian setting – Dr Nicholas Bull
13:39 – 13:48
Malignant Transformation of Intraductal Papillary Mucinous Neoplasm (IPMN): a Multi-centre Retrospective Analysis from the IPMN Registry – Dr Edward Meehan
13:48 – 13:57
Circulating Tumour Cells as a Prognostic Biomarker for Resectable Pancreatic Ductal Adenocarcinoma: Pilot Study – Dr Doruk Seyfi
13:57 – 14:06
Outcomes following pancreaticoduodenectomy for octogenarians: a systematic review and meta-analysis – Dr Kai Zheong Lim
14:06 – 14:15
The utility of Braun Enteroenterostomy with pancreaticoduodenectomy: Systematic Review and Meta-Analysis of Randomised Controlled Trials – Dr Saksham Gupta
14:15 – 14:24
Partial Splenectomy in Distal Pancreatectomy can preserve Splenic Function – Dr Nick O’Rourke
14:24 – 14:33
Outcomes of Endoscopic Ultrasound-Guided Gastro-Enterostomy for Gastric Outlet Obstruction in a Two Centre Australian Cohort – Dr Martin Harb
14:33 – 14:42
Portal vein resection in pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis of case-matched studies – Dr Alen Brodaric
14:42 – 14:51
Robotic approach to pancreaticoduodenectomy is feasible in patients with aberrant arterial anatomy
– Dr Joel Lewin
14:51 – 15:00
Evolution of Laparoscopic Pancreaticoduodenectomy at Westmead Hospital- Oral Presentation – Dr Ji Chen
Patient-centered care and PROMS in HPB surgery
Chairs Dr Eu Ling Neo and Dr Nicholas Bull
Chairs Dr Eu Ling Neo and Dr Nicholas Bull
15:30 – 15:45
Day only laparoscopic cholecystectomy – Arthur Richardson
15:45 – 16:00
Laparoscopic cholecystectomy for functional GB disorders – Dr Gratian Punch
16:00 – 16:15
Cyst excision (fenestration) of benign liver cysts – Dr Kai Brown
16:15 – 16:30
Debulking liver resection for NET liver metastases – Dr Peter Carr-Boyd
16:30 – 16:45
Downstaging neoadjuvant treatment of advanced pancreatic adenocarcinoma – Dr Chris Nahm
16:45 – 17:00
Discussion
Conference Dinner at 7pm
Ballroom at the InterContinental
Ballroom at the InterContinental
DAY TWO - Friday 6th October
7:00 to 8:30
Session is held in the Keltie Cove Room
Breakfast is supplied for attendees
Breakfast is supplied for attendees
- 30min – Ultrasound physics, universal basics and considerations – Kim Theil – BK Medical International Product Specialist
- 30min – BK Ultrasound system familiarity, functionality, and workflows. – Adrian Barker – BK Medical National Product Manager
- 30mins – Hands-on workstations.
Clinical decision making and consent in HPB surgery – Chairs Dr Michael Crawford and Dr Emily Olive
8:30 to 8:45 – Tailoring diagnosis and treatment for patients with gallstones – Dr Phil de Reuver
8:45 to 9:00 – Cholecystectomy for gallbladder polyps – is it ever appropriate? Professor Jonathan Koea
9:00 to 9:15 – Consent in HPB surgery – what do you tell the patient? – Professor Vijayaragavan Muralidharan
9:15 to 9:30 – The value and limitations of the MDT meeting for HPB cancers – Dr Charles Pilgrim
9:30 to 9:45 – HPB cancer surgery -the anaesthetists/intensivist perspective – Dr Benjamin Olesnicky
9:45 to 10:00 – Discussion
10:00 to 10:30
Keynote talk “Evaluating Surgical Innovation”
Introduction – Professor Tom Hugh
Speaker – Professor David Beard
Professor and Surgical & Complex Intervention Trials Program Lead at the NHMRC CTC, University of Sydney – Professor of Musculoskeletal and Surgical Sciences at the Nuffield – Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) in the University of Oxford – Director of the Royal College of Surgeons (RCS) Surgical Intervention Trials Unit (SITU-NDORMS)
The role of innovation and technology in value-based care in HPB surgery – Chairs Dr Eunice Lee and Dr Joel Lewin
11:00 to 11:15 – Surgical outcomes are improved by the devices and equipment we use (stapling and energy devices, 3D systems, 4K monitors) – Professor Vincent Lam
11:15 to 11:30 – Laparoscopy has improved the value of HPB surgery – Dr Mehan Siriwardhane
11:30 to 11:45 – Robotics has improved the value of HPB surgery – Dr David Cavallucci
11:45 to 12:00 – Where does the learning curve of MIS tip to gain the benefits – Dr David Yeo
12:00 to 12:15 – Who decides on whether new technology in HPB surgery should be used? Professor Guy Maddern
12:15 to 12:30 – Discussion
12:30 to 12:40 – AGM
Free papers: Pancreas (Prize for best presentation) – Chairs Dr Ben Loveday and Dr Dan Kilburn
13:30 to 13:39 – Markov model decision analysis suggests that screening guidelines for branch duct intraductal papillary mucinous neoplasms <3cm are not cost effective in an Australian setting – Dr Nicholas Bull
13:39 to 13:48 – Malignant Transformation of Intraductal Papillary Mucinous Neoplasm (IPMN): a Multi-centre Retrospective Analysis from the IPMN Registry – Dr Edward Meehan
13:48 to 13:57 – Circulating Tumour Cells as a Prognostic Biomarker for Resectable Pancreatic Ductal Adenocarcinoma: Pilot Study – Dr Doruk Seyfi
13:57 to 14:06 – Outcomes following pancreaticoduodenectomy for octogenarians: a systematic review and meta-analysis. – Dr Kai Zheong Lim
14:06 to 14:15 – The utility of Braun Enteroenterostomy with pancreaticoduodenectomy: Systematic Review and Meta-Analysis of Randomised Controlled Trials – Dr Saksham Gupta
14:15 to 14:24 – Partial Splenectomy in Distal Pancreatectomy can preserve Splenic Function – Dr Nick O’Rourke
4:24 to 14:33 – Outcomes of Endoscopic Ultrasound-Guided Gastro-Enterostomy for Gastric Outlet Obstruction in a Two Centre Australian Cohort – Dr Martin Harb
14:33 to 14:42 – Portal vein resection in pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: a systematic review and meta-analysis of case-matched studies – Dr Alen Brodaric
14:42 to 14:51 – Robotic approach to pancreaticoduodenectomy is feasible in patients with aberrant arterial anatomy – Dr Joel Lewin
14:51 to 15:00 – Evolution of Laparoscopic Pancreaticoduodenectomy at Westmead Hospital- Oral Presentation – Dr Ji Chen
Patient-centered care and PROMS in HPB surgery – Chairs Dr Eu Ling Neo and Dr Nicholas Bull
15:30 to 15:45 – Day only laparoscopic cholecystectomy – Arthur Richardson
15:45 to 16:00 – Laparoscopic cholecystectomy for functional GB disorders – Dr Gratian Punch
16:00 to 16:15 – Cyst excision (fenestration) of benign liver cysts – Dr Kai Brown
16:15 to 16:30 – Debulking liver resection for NET liver metastases – Dr Peter Carr-Boyd
16:30 to 16:45 – Downstaging neoadjuvant treatment of advanced pancreatic adenocarcinoma – Dr Chris Nahm
16:45 to 17:00 – Discussion
Conference Dinner at 7pm
Ballroom at the InterContinental
Ballroom at the InterContinental